1. Home
  2. AVTE vs LPTH Comparison

AVTE vs LPTH Comparison

Compare AVTE & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTE
  • LPTH
  • Stock Information
  • Founded
  • AVTE 2018
  • LPTH 1985
  • Country
  • AVTE United States
  • LPTH United States
  • Employees
  • AVTE N/A
  • LPTH N/A
  • Industry
  • AVTE Biotechnology: Pharmaceutical Preparations
  • LPTH Semiconductors
  • Sector
  • AVTE Health Care
  • LPTH Technology
  • Exchange
  • AVTE Nasdaq
  • LPTH Nasdaq
  • Market Cap
  • AVTE 72.5M
  • LPTH 81.1M
  • IPO Year
  • AVTE 2021
  • LPTH 1996
  • Fundamental
  • Price
  • AVTE $2.75
  • LPTH $2.02
  • Analyst Decision
  • AVTE Hold
  • LPTH Strong Buy
  • Analyst Count
  • AVTE 7
  • LPTH 3
  • Target Price
  • AVTE $11.75
  • LPTH $4.67
  • AVG Volume (30 Days)
  • AVTE 192.3K
  • LPTH 118.7K
  • Earning Date
  • AVTE 05-12-2025
  • LPTH 05-08-2025
  • Dividend Yield
  • AVTE N/A
  • LPTH N/A
  • EPS Growth
  • AVTE N/A
  • LPTH N/A
  • EPS
  • AVTE N/A
  • LPTH N/A
  • Revenue
  • AVTE N/A
  • LPTH $32,158,517.00
  • Revenue This Year
  • AVTE N/A
  • LPTH $16.90
  • Revenue Next Year
  • AVTE N/A
  • LPTH $52.77
  • P/E Ratio
  • AVTE N/A
  • LPTH N/A
  • Revenue Growth
  • AVTE N/A
  • LPTH N/A
  • 52 Week Low
  • AVTE $1.25
  • LPTH $1.04
  • 52 Week High
  • AVTE $25.29
  • LPTH $4.42
  • Technical
  • Relative Strength Index (RSI)
  • AVTE 72.33
  • LPTH 49.64
  • Support Level
  • AVTE $2.61
  • LPTH $1.61
  • Resistance Level
  • AVTE $2.82
  • LPTH $1.93
  • Average True Range (ATR)
  • AVTE 0.11
  • LPTH 0.19
  • MACD
  • AVTE 0.02
  • LPTH 0.04
  • Stochastic Oscillator
  • AVTE 81.08
  • LPTH 65.08

About AVTE Aerovate Therapeutics Inc.

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.

Share on Social Networks: